Please login to the form below

Not currently logged in

diroximel fumarate

This page shows the latest diroximel fumarate news and features for those working in and with pharma, biotech and healthcare.

SMC approves Biogen’s Vumerity for patients with multiple sclerosis

SMC approves Biogen’s Vumerity for patients with multiple sclerosis

Biogen’s Vumerity (diroximel fumarate) has been approved by the Scottish Medicines Consortium (SMC) as an oral treatment for adults with relapsing-remitting multiple sclerosis (RRMS). ... The SMC based its decision on results from pivotal phase 3

Latest news

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....